SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-003496
Filing Date
2021-11-08
Accepted
2021-11-08 16:53:19
Documents
72
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q dawn-20210930.htm   iXBRL 10-Q 3123567
2 EX-31.1 dawn-ex31_1.htm EX-31.1 14983
3 EX-31.2 dawn-ex31_2.htm EX-31.2 15025
4 EX-32.1 dawn-ex32_1.htm EX-32.1 9276
5 EX-32.2 dawn-ex32_2.htm EX-32.2 10391
6 GRAPHIC img10798652_0.jpg GRAPHIC 72832
  Complete submission text file 0000950170-21-003496.txt   8798228

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT dawn-20210930_def.xml EX-101.DEF 261505
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dawn-20210930_pre.xml EX-101.PRE 352304
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT dawn-20210930_cal.xml EX-101.CAL 36154
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dawn-20210930_lab.xml EX-101.LAB 408381
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dawn-20210930.xsd EX-101.SCH 57664
12 EXTRACTED XBRL INSTANCE DOCUMENT dawn-20210930_htm.xml XML 1209759
Mailing Address 395 OYSTER POINT BLVD STE 217 SOUTH SAN FRANCISCO CA 94080-1930
Business Address 395 OYSTER POINT BLVD STE 217 SOUTH SAN FRANCISCO CA 94080-1930 206-913-4300
Day One Biopharmaceuticals, Inc. (Filer) CIK: 0001845337 (see all company filings)

IRS No.: 832415215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40431 | Film No.: 211388681
SIC: 2834 Pharmaceutical Preparations